Rationale: Extraskeletal myxoid chondrosarcoma (EMC) is a rare malignant neoplasm of which intracranial EMC is the rarest.
Patient Concerns: We present an unusual case report of a 41-year-old woman who was sent to the emergency department for a sudden headache and other symptoms related to increased intracranial pressure.
Interventions: Emergent CT revealed an occupying lesion in the left cerebellum with surrounding edema. A complete surgical excision of the lesion through a transcortical approach was performed. After the operation, this patient received adjuvant radiotherapy and temozolomide treatment.
Diagnoses: Pathology diagnosis was an intracranial EMC.
Outcomes: The patient survives with no tumor recurrence as of the last follow-up. Progression-free survival exceeded 20 months.
Lessons: We have reviewed the literature and here summarize the diagnosis and treatment options for intracranial EMC. Diagnosis and treatment options of this rare disease are discussed.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708947 | PMC |
| http://dx.doi.org/10.1097/MD.0000000000008684 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Laparoscopic-Assisted, Percutaneous Cryoablation: A Novel Technique for the Treatment of Abdominal Wall Soft Tissue Tumors.
Ann Surg Oncol
January 2025
Department of Surgery, Atrium Health Carolinas Medical Center, Charlotte, NC, USA.
Introduction: Percutaneous cryoablation is a first-line therapeutic option for primary neoplasms and metastatic lesions of the musculoskeletal system. Treatment of abdominal wall tumors is challenging as surgical resection can be highly morbid and necessitate complex reconstructive surgery; the efficacy of cryoablation for abdominal wall tumors may be limited by inadequate posterior margins owing to the proximity of intra-abdominal organs. With laparoscopy and insufflation, peritoneal structures can be safely mobilized away from the abdominal wall, allowing for adequate deep margin freeze and visualization of the ice ball.
View Article and Find Full Text PDFClinical, imaging and pathological features of extraskeletal myxoid chondrosarcoma.
Skeletal Radiol
September 2024
Division of Musculoskeletal Imaging and Intervention, Department of Radiology, Massachusetts General Hospital, Yawkey 6E 55 Fruit Street, Boston, MA, 02114, USA.
Objective: To evaluate clinical and radiological features of extraskeletal myxoid chondrosarcomas (EMC).
Material And Methods: Our pathology database was queried for cases of EMCs. Tumor location, size, imaging appearance, presence of metastases, disease recurrence, and clinical outcome were documented.
Primary extraskeletal osteosarcomas of the pleura: A clinicopathological, immunohistochemical, and molecular analysis of 4 cases.
Hum Pathol
October 2024
Department of Anatomic Pathology, The University of Texas MD Anderson Cancer Center, Houston, USA.
Four primary extraskeletal osteosarcomas of the pleura are presented. The patients were men between the ages of 63 and 78 years (average: 70.5 years) who presented with symptoms of chest pain, cough, and shortness of breath.
View Article and Find Full Text PDFWhole genome sequencing for metastatic mutational burden in extraskeletal myxoid chondrosarcoma.
Front Mol Med
July 2023
Musculoskeletal Oncology Laboratory, Department of Orthopaedic Surgery, University of Pittsburgh School of Medicine, Pittsburgh, PA, United States.
Extraskeletal myxoid chondrosarcoma (EMC) is an ultra-rare cancer that makes up less than 3% of all soft tissue sarcomas. It most often arises in the soft tissues of the proximal limbs and has a higher incidence in males. Though EMC has a good prognosis, it has an indolent course with high rates of local recurrence as well as metastasis to the lungs.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!